Viewing StudyNCT03025542



Ignite Creation Date: 2024-05-06 @ 9:36 AM
Last Modification Date: 2024-10-26 @ 12:17 PM
Study NCT ID: NCT03025542
Status: COMPLETED
Last Update Posted: 2022-10-28
First Post: 2017-01-17

Brief Title: A Study to Evaluate the Pharmacokinetics PK Pharmacodynamics PD and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Chronic Plaque Psoriasis
Keywords:
Name View
Psoriasis View
Chronic Plaque Psoriasis View
Bimekizumab View